Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Second Cancers in Breast Cancer Survivors: A Systematic Review



Foumani RS1 ; Farshidmehr P2 ; Mahmoudabadi HZ3 ; Rahimpour E4 ; Tajdini F5 ; Madani FK6 ; Monfared ED7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Assistant Professor of Community Medicine, Department of Community Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Assistant Professor of Vascular Surgery, Sina Hospital, Department of Vascular Surgery, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Surgery, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Tehran, Iran
  4. 4. Professor of General Surgery, Sina hospital, Department of Surgery, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Community Medicine Specialist, Department of Community Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Medical Student, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. Health Management Research Center, Department of Community Medicine, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

Source: Journal of Advanced Pharmacy Education and Research Published:2020

Abstract

Introduction: Breast cancer is one of the most important problems in general health of women in the world. Advances in the treatment have led to longevity of patients, resulting in the risk of other diseases, including second cancers. The aim of this study was to determine the types and risks of second primary cancers after breast cancer. Methods: A protocol was developed and a sensitive search in databases including PubMed, PubMed central, and Google scholar and also in the list of referenced articles was conducted without time limitation. All letters, comments, editorial studies and studies about breast cancer metastases and inhumane studies were excluded. The quality of papers was verified with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Results: 15 papers were selected and reviewed, including colorectal, bone marrow malignancies, esophageal cancer, soft tissue sarcoma, lung cancer, thyroid malignancies and ovarian cancer as second cancers in breast cancer patient. These articles declared their review and findings regarding these cancers as second cancer after breast cancer. All of these second cancers were associated with chemotherapy and/or auxiliary radiotherapy, especially intensive doses of radiation. Conclusion: The studies have been shown the treatment approach of BC may be the main cause of second cancer development after BC which consisted of bone marrow neoplasm, sarcoma, thyroid, esophageal, lung and uterine cancer. Intensive radiotherapy and chemotherapy had the potential risk of second cancer development, as well as they had syngism effect with each other. © 2020 Journal of Advanced Pharmacy Education & Research | Published by SPER Publication
Related Docs
1. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
2. Rectal Cancer: A Review, Medical Journal of the Islamic Republic of Iran (2015)
3. Curcumin As an Anti-Inflammatory Agent: Implications to Radiotherapy and Chemotherapy, Journal of Cellular Physiology (2019)
4. Mobile Applications in Breast Cancer Postoperative Care: A Scoping Review, Cancer Medicine (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Reza Keramati (1)
Shirzad Nasiri (1)